Health Officials Ethics Reform: Restrictions on Industry Jobs and Drug Patents.
This bill imposes strict limitations on former high-ranking officials from key health agencies (NIH, FDA, CDC) to prevent conflicts of interest. The goal is to increase public trust in regulatory decisions regarding drugs and medical devices. These officials face an 8-year ban on serving on pharmaceutical company boards and are prohibited from profiting from products related to grants they approved.
Key points
Imposes an 8-year ban on top former NIH, FDA, and CDC officials from serving on the boards of companies researching or manufacturing drugs and devices.
Prohibits former employees from profiting from drugs or devices if they were directly involved in approving related grant applications (subject to penalties and imprisonment).
Requires top officials and their spouses to disclose any ownership or financial interest in patents for drugs, biological products, or devices.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.